These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1922110)

  • 21. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme-independent, orientation-selective conjugation of whole human complement C3 to protein surfaces.
    Mitchell DA; Ilyas R; Dodds AW; Sim RB
    J Immunol Methods; 2008 Aug; 337(1):49-54. PubMed ID: 18572187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and structural characterization of four mouse monoclonal antibodies to complement C3 with potential therapeutic and diagnostic applications.
    Subías Hidalgo M; Yébenes H; Rodríguez-Gallego C; Martín-Ambrosio A; Domínguez M; Tortajada A; Rodríguez de Córdoba S; Llorca O
    Eur J Immunol; 2017 Mar; 47(3):504-515. PubMed ID: 28083930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and initial characterisation of complement components C3 and C4 of the nurse shark and the channel catfish.
    Dodds AW; Smith SL; Levine RP; Willis AC
    Dev Comp Immunol; 1998; 22(2):207-16. PubMed ID: 9639090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of porcine C3. Studies of the biologically active protein and its split products.
    Storm KE; Arturson G; Nilsson UR
    Vet Immunol Immunopathol; 1992 Oct; 34(1-2):47-61. PubMed ID: 1441229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covalent binding and hemolytic activity of complement proteins.
    Law SK; Lichtenberg NA; Levine RP
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7194-8. PubMed ID: 6938964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous thioester bond formation in alpha 2-macroglobulin, C3 and C4.
    Pangburn MK
    FEBS Lett; 1992 Aug; 308(3):280-2. PubMed ID: 1380468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autolytic fragmentation of complement components C3 and C4 and its relationship to covalent binding activity.
    Sim RB; Sim E
    Ann N Y Acad Sci; 1983; 421():259-76. PubMed ID: 6202197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the thioester bond in C3 and C4 in the determination of the conformational and functional states of the molecule.
    Isenman DE
    Ann N Y Acad Sci; 1983; 421():277-90. PubMed ID: 6202198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometry based detection of HLA alloantibody mediated classical complement activation.
    Wahrmann M; Exner M; Regele H; Derfler K; Körmöczi GF; Lhotta K; Zlabinger GJ; Böhmig GA
    J Immunol Methods; 2003 Apr; 275(1-2):149-60. PubMed ID: 12667679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.
    Nilsson B; Nilsson Ekdahl K; Avila D; Nilsson UR; Lambris JD
    Biochem J; 1990 May; 268(1):55-61. PubMed ID: 1693076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation.
    Stewart WW; Johnson A; Steward MW; Whaley K; Kerr MA
    Mol Immunol; 1988 Dec; 25(12):1355-61. PubMed ID: 3266294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple alternative pathway for hemolytic assay of human complement component C3 using methylamine-treated plasma.
    Jessen TE; Barkholt V; Welinder KG
    J Immunol Methods; 1983 May; 60(1-2):89-100. PubMed ID: 6406606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung injury induced by antibody fragments to angiotensin-converting enzyme.
    Caldwell PR; Wigger HJ; Fernandez LT; D'Alisa RM; Tse-Eng D; Butler VP; Gigli I
    Am J Pathol; 1981 Oct; 105(1):54-63. PubMed ID: 6271015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies.
    Schaapherder AF; Gooszen HG; te Bulte MT; Daha MR
    Transplantation; 1995 Aug; 60(3):287-91. PubMed ID: 7645041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.
    Nilsson B; Grossberger D; Nilsson Ekdahl K; Riegert P; Becherer DJ; Nilsson UR; Lambris JD
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):715-21. PubMed ID: 1372802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complementing antibody profiles: assessing antibody function on antigen microarrays.
    Prechl J; Szittner Z; Papp K
    Immunol Lett; 2012 Mar; 143(1):101-5. PubMed ID: 22306105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of factors influencing on-chip complement activation to optimize parallel measurement of antibody and complement proteins on antigen microarrays.
    Papp K; Végh P; Hóbor R; Erdei A; Prechl J
    J Immunol Methods; 2012 Jan; 375(1-2):75-83. PubMed ID: 22000977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.